FDA Approvals of 2012

>
34 of 39
<

Signifor

Drug: Signifor
Generic molecule: pasireotide diaspartate
Company: Novartis
Approval date: Dec. 14

The scoop: The FDA's approval of injectable pasireotide diaspartate to treat the underlying mechanism causing Cushing's disease provides a new option for patients suffering from the disease, which until now has been treated by surgery.